ATreaon's Series A Round

ATreaon raised a round of funding on October 26, 2011. Investors include Morningside Group (晨兴集团).

ATreaon is a pharmaceutical company that has designed a molecule based on the growth factor proganulin that could help treat rheumatoid arthritis and other autoimmune diseases.…

Articles about ATreaon's Series A Round: